Nevertheless, positive and negative effects of this Th1-associated cytokine in ICI therapy have been reported, and recent reports show that the influence of IFN-γ in cancer immunotherapy goes beyond the PD-1/PD-L1 pathway. This evidence concerns the gene CD274 and cancer.